![Robert Schwartz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert Schwartz
Gründer bei Corflow Therapeutics AG
Ursprung des Netzwerks ersten Grades von Robert Schwartz
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Corflow Therapeutics AG
![]() Corflow Therapeutics AG Medical SpecialtiesHealth Technology Corflow Therapeutics AG is a company based in Switzerland that is developing proprietary technologies to measure the coronary microvascular status and provide therapy to the compromised coronary microcirculation at the same time in the catheter laboratory. The Swiss company's focus is on treating microvascular obstruction (MVO) after an acute heart attack, which is documented to be an independent marker leading to costly complications such as heart failure. Corflow's technologies may enable interventional cardiologists to treat MVO in severe heart attack patients, thereby potentially reducing the short- and long-term complication rates in these patients. The company was founded in 2016 by Martin T. Rothman and Robert S. Schwartz.
4
| Holding Company | Medical Specialties | 4 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Robert Schwartz
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Medtronic, Inc.
![]() Medtronic, Inc. Medical SpecialtiesHealth Technology Medtronic, Inc. operates as a medical technology company. It offers implantable cardiac pacemakers, eternal defibrillators, inferior turbinate surgery products, and continuous glucose monitoring device. The company was founded by Earl E. Bakken and Palmer J. Hermundslie on April 29, 1949 and is headquartered in Minneapolis, MN. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
SONENDO, INC. | Medical Specialties | Director/Board Member | |
Thommen Medical AG
![]() Thommen Medical AG Medical SpecialtiesHealth Technology Thommen Medical AG develops and manufactures dental implant systems. It offers include implants, prosthetics, digital solutions, and case planning. The company Grenchen, Switzerland. | Medical Specialties | Director/Board Member | |
Sofinnova Partners SAS
![]() Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Private Equity Investor | |
University of London | College/University | Corporate Officer/Principal | |
The Ohio State University
![]() The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | College/University | Undergraduate Degree | |
FLERIE INVEST AB | Pharmaceuticals: Major | Director/Board Member | |
WEIFA ASA | Pharmaceuticals: Major | Director/Board Member | |
University of Oslo | College/University | Doctorate Degree | |
Neomed Management AS
![]() Neomed Management AS Investment ManagersFinance Neomed Management AS is an investment firm based in Oslo. Founded in 1998, the firm specializes in private equity investments in the healthcare and life science sectors. Neomed advises several funds namely NeoMed I, II, III, IV and V. | Investment Managers | Founder | |
JenaValve Technology GmbH
![]() JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | Medical Specialties | Director/Board Member Director/Board Member | |
Barts & The London NHS Trust
![]() Barts & The London NHS Trust Hospital/Nursing ManagementHealth Services Barts & The London NHS Trust provides health care services in hospitals. Its services include air ambulance, hepatology, anaesthetics and pain management, haematology, paediatric respiratory, emergency department, endocrinology, Urology, and many more. The company is headquartered in Aldgate, the United Kingdom. | Hospital/Nursing Management | Chief Tech/Sci/R&D Officer | |
Sequana Medical AG
![]() Sequana Medical AG Medical SpecialtiesHealth Technology Sequana Medical AG operates as a medical device company. It specializes in the production and design of implantable pump systems to manage fluid balance within the body. The firm offers the Alfapump system, its proprietary solution to manage and remove ascites, which can occur as a symptom of liver disease, cancer, or congestive heart failure and its focus areas encompass clinical research, product innovation, and technology development. The company was founded by Noel L. Johnson in 2000 and is headquartered in Zurich, Switzerland. | Medical Specialties | Director/Board Member | |
Glenwood Management
![]() Glenwood Management Real Estate DevelopmentFinance Glenwood Management develops, owns, manages, and rents apartments. The private company is based in New York, NY and has subsidiaries in the United States. | Real Estate Development | Corporate Officer/Principal | |
JenaValve Technology, Inc.
![]() JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Medical Specialties | Director/Board Member | |
Norwegian Venture Capital & Private Equity Association | Founder | ||
Omega Fund Management LLC
![]() Omega Fund Management LLC Investment ManagersFinance Omega Fund Management Ltd. (OFM) is the wholly-owned private equity firm founded by Dr. Otello Stampacchia in 2004. The firm is headquartered in the US. | Investment Managers | Consultant / Advisor | |
Hd Clinical | Director/Board Member | ||
Site Specific Therapies Ltd. | Director/Board Member | ||
PerQtech Ltd. | Director/Board Member | ||
Heart Cells Foundation | Director/Board Member | ||
HighLife SAS
![]() HighLife SAS Medical SpecialtiesHealth Technology HighLife SAS develops percutaneous mitral valve replacement therapies. It offers a minimally invasive prosthetic mitral valve that is implanted on a beating heart, while preserving the native valve structure and respecting the surrounding anatomy. The company was founded by Georg Börtle in 2010 and is headquartered in Paris, France. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Stanford Graduate School of Business | College/University | Graduate Degree | |
AXONICS, INC. | Medical Specialties | Director/Board Member | |
RELIEF THERAPEUTICS HOLDING SA | Pharmaceuticals: Major | Director of Finance/CFO | |
Qiagen AS | Director/Board Member | ||
LimFlow SA
![]() LimFlow SA Medical SpecialtiesHealth Technology LimFlow SA develops and offers medical devices which transformes the treatment of critical limb Ischemi. The firm?s proprietary and CE marked technology is a novel and purely percutaneous therapy for ?no-option? CLI patients. The company was founded by Martin T. Rothman in 2012 and is headquartered in Paris, France. | Medical Specialties | Founder | |
SEQUANA MEDICAL N.V. | Medical Specialties | Director/Board Member | |
Serca Pharmaceuticals AS
![]() Serca Pharmaceuticals AS Pharmaceuticals: MajorHealth Technology Serca Pharmaceuticals AS develops, markets, and sells drug treatment products, medicinal products, and equipment for injuries. The company was founded on October 8, 2018 and is headquartered in Lysaker, Norway. | Pharmaceuticals: Major | Director/Board Member | |
Origo Ventures AS | President |
Statistik
International
Vereinigte Staaten | 11 |
Vereinigtes Königreich | 10 |
Norwegen | 10 |
Schweiz | 5 |
Frankreich | 4 |
Sektoral
Health Technology | 22 |
Finance | 5 |
Consumer Services | 5 |
Health Services | 3 |
Distribution Services | 2 |
Operativ
Director/Board Member | 27 |
Chairman | 5 |
Founder | 4 |
Independent Dir/Board Member | 3 |
Chief Tech/Sci/R&D Officer | 3 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Erik Amble | 23 |
Martin T. Rothman | 16 |
Timothy Snyder | 4 |
Gunnar M. Páh | 1 |
- Börse
- Insiders
- Robert Schwartz
- Unternehmensverbindungen